Offer to purchase CLEARNET.pdf - About TELUS
Offer to purchase CLEARNET.pdf - About TELUS
Offer to purchase CLEARNET.pdf - About TELUS
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>TELUS</strong> CORPORATION<br />
(FORMERLY BCT.<strong>TELUS</strong> COMMUNICATIONS INC.)<br />
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)<br />
December 31, 1999<br />
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)<br />
Revenue from operating leases of equipment is recognized when service is rendered <strong>to</strong> cus<strong>to</strong>mers. The<br />
leased equipment is depreciated in accordance with the Company’s depreciation policy.<br />
(j) Other Long-term Liabilities<br />
Included in Other Long-term Liabilities are contributions from the Government of Alberta under the<br />
Individual Line Service program, which are recognized as income on a straight-line basis over the estimated<br />
useful life of the related assets. The amount <strong>to</strong> be recognized as income within one year is included with<br />
Advance Billings and Cus<strong>to</strong>mer Deposits in the Consolidated Balance Sheet.<br />
(k) Research and Development<br />
Research and development costs are expensed in the period in which they are incurred unless they meet<br />
certain identifiable criteria for deferral. Research and development costs expensed during the year<br />
amounted <strong>to</strong> $2.5 million ($61.6 million — 1998).<br />
(l) Translation of Foreign Currencies<br />
Trade transactions completed in foreign currencies are translated in<strong>to</strong> Canadian dollars at the rates<br />
prevailing at the time of the transactions. Monetary assets and liabilities denominated in foreign currencies<br />
are translated in<strong>to</strong> equivalent Canadian dollars at the rate of exchange in effect at the balance sheet date<br />
with any resulting gain or loss being expensed. Gains or losses arising from translation of non-current<br />
monetary liabilities are deferred and amortized over the remaining lives of the related liabilities.<br />
(m) Financial Instruments<br />
The Company’s financial instruments consist of cash and temporary investments, accounts receivable, leases<br />
receivable, sinking fund assets, bank indebtedness, accounts payable and accrued liabilities, dividends<br />
payable, notes payable under commercial paper programs and long-term debt.<br />
The carrying value of cash and temporary investments, bank indebtedness, accounts receivable, leases<br />
receivable, accounts payable and accrued liabilities, dividends payable and notes payable under commercial<br />
paper programs approximates their fair values due <strong>to</strong> the immediate or short-term maturity of these<br />
financial instruments. The fair values of the Company’s sinking fund assets are determined by quoted<br />
market prices at the balance sheet date. The fair value of the Company’s long-term debt is estimated based<br />
on quoted market prices for the same or similar issues or on the current rates offered <strong>to</strong> the Company for<br />
debt of the same maturity as well as the use of discounted future cash flows using current rates for similar<br />
financial instruments subject <strong>to</strong> similar risks and maturities. As of December 31, 1999 the estimated fair<br />
value of long-term debt exceeded the carrying value by approximately $249 million ($463 million — 1998).<br />
The Company is exposed <strong>to</strong> interest rate risk arising from fluctuations in interest rates on its temporary<br />
investments, sinking fund assets, notes payable under commercial paper programs and long-term debt.<br />
The Company uses various financial instruments which are not reflected on the balance sheet <strong>to</strong> reduce or<br />
eliminate exposure <strong>to</strong> interest rate and currency risks, and as part of structured financing. These<br />
instruments are accounted for on the same basis as the underlying exposure being hedged. At December 31,<br />
1999, the <strong>to</strong>tal notional amount of derivative financial instruments outstanding was $442.4 million<br />
($416.5 million — 1998). The fair market value of these instruments at December 31, 1999 exceeded their<br />
I-12